BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 1530115)

  • 1. Effectiveness of nationwide screening program for neuroblastoma in Japan.
    Hisashige A;
    Glob J Health Sci; 2014 Apr; 6(4):94-106. PubMed ID: 25001552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spontaneous regression of neuroblastoma.
    Brodeur GM
    Cell Tissue Res; 2018 May; 372(2):277-286. PubMed ID: 29305654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroblastoma, a Paradigm for Big Data Science in Pediatric Oncology.
    Salazar BM; Balczewski EA; Ung CY; Zhu S
    Int J Mol Sci; 2016 Dec; 18(1):. PubMed ID: 28035989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nordihydroguaiaretic acid inhibits insulin-like growth factor signaling, growth, and survival in human neuroblastoma cells.
    Meyer GE; Chesler L; Liu D; Gable K; Maddux BA; Goldenberg DD; Youngren JF; Goldfine ID; Weiss WA; Matthay KK; Rosenthal SM
    J Cell Biochem; 2007 Dec; 102(6):1529-41. PubMed ID: 17486636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adrenal surgery in the pediatric population.
    Misseri R
    Curr Urol Rep; 2007 Jan; 8(1):89-94. PubMed ID: 17239322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neonatal neuroblastoma.
    Moppett J; Haddadin I; Foot AB
    Arch Dis Child Fetal Neonatal Ed; 1999 Sep; 81(2):F134-7. PubMed ID: 10448183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The physician's hands and early detection of neuroblastoma.
    Armata J; Hnatko-Kolacz M
    Arch Dis Child; 1994 Mar; 70(3):253. PubMed ID: 8135579
    [No Abstract]   [Full Text] [Related]  

  • 8. Is neuroblastoma screening evaluation needed and feasible?
    Estève J; Parker L; Roy P; Herrmann F; Duffy S; Frappaz D; Lasset C; Hill C; Sancho-Garnier H; Michaelis J
    Br J Cancer; 1995 Jun; 71(6):1125-31. PubMed ID: 7779698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamics of cell proliferation and cell death during the emergence of primitive neuroectodermal tumors of the immature central nervous system in transgenic mice.
    Fung KM; Lee VM; Trojanowski JQ
    Am J Pathol; 1995 Jun; 146(6):1376-87. PubMed ID: 7778677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin-like growth factor II in the pathogenesis of human neuroblastoma.
    Sullivan KA; Castle VP; Hanash SM; Feldman EL
    Am J Pathol; 1995 Dec; 147(6):1790-8. PubMed ID: 7495303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Present status of neuroblastoma mass screening in Japan. Neuroblastoma-Committee of the Japanese Childhood Cancer Society].
    Sawada T; Nagahara N; Ohi R; Yamamoto K; Okabe I; Hanawa Y; Hashizume K; Matsui I; Ohkawa H; Tunoda A
    Gan To Kagaku Ryoho; 1990 Dec; 17(12):2319-26. PubMed ID: 2260868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Neuroblastoma: epidemiology and spontaneous remission. Significance for evaluation of screening studies].
    Carlsen NL
    Ugeskr Laeger; 1992 Dec; 154(52):3742-6. PubMed ID: 1471302
    [No Abstract]   [Full Text] [Related]  

  • 13. [Neuroblastoma in children: clinical and biological aspects. An experience of screening in France].
    Mathieu P; Favrot M; Frappaz D; Chauvin F; Greffe J; Montegue A; Lacroix C; David L; Brunat-Mentigny M; Philip T
    Ann Biol Clin (Paris); 1993; 51(7-8):665-88. PubMed ID: 8166384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroblastoma: epidemiology and pattern of regression. Problems in interpreting results of mass screening.
    Carlsen NL
    Am J Pediatr Hematol Oncol; 1992 May; 14(2):103-10. PubMed ID: 1530115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Why age has independent prognostic significance in neuroblastomas. Evidence for intra-uterine development, and implications for the treatment of the disease.
    Carlsen NL
    Anticancer Res; 1988; 8(2):255-62. PubMed ID: 3364937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological aspects of neuroblastomas identified by mass screening in Quebec.
    Brodeur GM; Look AT; Shimada H; Hamilton VM; Maris JM; Hann HW; Leclerc JM; Bernstein M; Brisson LC; Brossard J; Lemieux B; Tuchman M; Woods WG
    Med Pediatr Oncol; 2001 Jan; 36(1):157-9. PubMed ID: 11464873
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.